GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » 3-Year Book Growth Rate

Raia Drogasil (BSP:RADL3) 3-Year Book Growth Rate : 11.00% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil 3-Year Book Growth Rate?

Raia Drogasil's Book Value per Share for the quarter that ended in Dec. 2023 was R$3.47.

During the past 12 months, Raia Drogasil's average Book Value per Share Growth Rate was 11.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 11.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was 10.80% per year. During the past 10 years, the average Book Value per Share Growth Rate was 10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Raia Drogasil was 87.70% per year. The lowest was -15.80% per year. And the median was 10.80% per year.


Competitive Comparison of Raia Drogasil's 3-Year Book Growth Rate

For the Pharmaceutical Retailers subindustry, Raia Drogasil's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's 3-Year Book Growth Rate falls into.



Raia Drogasil 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Raia Drogasil  (BSP:RADL3) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Raia Drogasil 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines